Editorial: New emerging functions of transcription factors and RNA-binding proteins in the development of hematological malignancies

Tarik Möröy; Cyrus Khandanpour

doi:10.3389/fonc.2023.1256461

Editorial: New emerging functions of transcription factors and RNA-binding proteins in the development of hematological malignancies

^*Korrespondierende/r Autor/-in für diese Arbeit

Jewish General Hospital and McGill University

Originalsprache	Englisch
Aufsatznummer	1256461
Zeitschrift	Frontiers in Oncology
Jahrgang	13
ISSN	2234-943X
DOIs	https://doi.org/10.3389/fonc.2023.1256461
Publikationsstatus	Veröffentlicht - 2023

Strategische Forschungsbereiche und Zentren

Profilbereich: Lübeck Integrated Oncology Network (LION)
Zentren: Universitäres Cancer Center Schleswig-Holstein (UCCSH)

DFG-Fachsystematik

205-14 Hämatologie, Onkologie

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

Zugriff auf Dokument

10.3389/fonc.2023.1256461

Andere Dateien und Links

Link to publication in Scopus

Zitieren

@article{d8764c241a974487be107d75ecb126cd,

title = "Editorial: New emerging functions of transcription factors and RNA-binding proteins in the development of hematological malignancies",

author = "Tarik M{\"o}r{\"o}y and Cyrus Khandanpour",

note = "Funding Information: TM received support from a CIHR (Canadian Institutes of Health Research) Foundation grant (FGN-148372). CK was supported by funds of the Max-Eder-Project of the Deutsche Krebshilfe, the Jose Carreras Leuk{\"a}mie-Stiftung and the Deutsche Forschungsgemeinschaft (DFG). ",

year = "2023",

doi = "10.3389/fonc.2023.1256461",

language = "English",

volume = "13",

journal = "Frontiers in Oncology",

issn = "2234-943X",

}

TY - JOUR

T1 - Editorial

T2 - New emerging functions of transcription factors and RNA-binding proteins in the development of hematological malignancies

AU - Möröy, Tarik

AU - Khandanpour, Cyrus

N1 - Funding Information: TM received support from a CIHR (Canadian Institutes of Health Research) Foundation grant (FGN-148372). CK was supported by funds of the Max-Eder-Project of the Deutsche Krebshilfe, the Jose Carreras Leukämie-Stiftung and the Deutsche Forschungsgemeinschaft (DFG).

PY - 2023

Y1 - 2023

UR - http://www.scopus.com/inward/record.url?scp=85168298697&partnerID=8YFLogxK

U2 - 10.3389/fonc.2023.1256461

DO - 10.3389/fonc.2023.1256461

M3 - Editorial

AN - SCOPUS:85168298697

SN - 2234-943X

VL - 13

JO - Frontiers in Oncology

JF - Frontiers in Oncology

M1 - 1256461

ER -